Community Based Participatory Research With Immigrant Chinese With Diabetes

NCT00833677 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2013-10-31

No results posted yet for this study

Summary

The proposed project is part of a program of research to improve management of type 2 diabetes (T2DM) through a community-academic partnership that addresses cultural factors in disease management. Specific aims are to: 1. Strengthen a community-academic partnership with the immigrant Chinese community in San Francisco to improve diabetes management; 2. Adapt and test a behavioral diabetes intervention, Coping Skills Training, to addresses family and cultural issues in immigrant Chinese patients with T2DM; and 3. Disseminate the adapted Coping Skills Training Program findings via the community-academic partnership to the immigrant Chinese American community through service programs, ethnic media, and professional/scientific publications. A mixed-methods CBPR approach will be used to interpretively adapt a behavioral intervention to be culturally appropriate, and test its efficacy using a repeated measures design. Two historically significant social service and health agencies serving immigrant Chinese in San Francisco are collaborating with this nurse-led interdisciplinary research team.

Conditions

Interventions

BEHAVIORAL

Chinese Coping Skills Training

Six-week group behavioral intervention: Chinese Coping Skills Training

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH
  • University of San Francisco

    collaborator OTHER
  • Donaldina Cameron House

    collaborator UNKNOWN
  • North East Medical Services

    collaborator UNKNOWN
  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Catherine Chesla, DNS · University of California, San Francisco

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00833677 on ClinicalTrials.gov